Qi Chao,Michael J. Hadd,Mark W. Holladay,Martin Rowbottom
申请号:
US13820119
公开号:
US20130303533A1
申请日:
2011.08.31
申请国别(地区):
US
年份:
2013
代理人:
摘要:
Provided herein are azolopyridine and azolopyrimidine compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.